Skip to main content

PHARMACODYNAMICS & Drug Receptor Interaction




>Pharmacodynamics deals with the biochemical and physiological effect of drug as well as its mechanism of action.  

                                    OR

We can simply define it as, The action of drug on the body.

 •Most drug exert effects, both beneficial and harmful, by interacting with specialized target macromollecule called receptor. 

Receptor : it refers to the drug binding site in the cell or on the surface of cell which mediate the action of drug. 
   • There are some drugs which do not require receptors Example = mannitol , anti-helmintic drugs, etc.

NATURE OF DRUG RECEPTOR
         1. Regulatory protein which mediates the action of endogenous chemical signals. For example : neurotransmitters , harmones and autocoids. 
         2. Enzymes. For example : dihydrofolic reductase
         3. Transport protein. For example : sodium / potassium ATPase pump. 
         4. Structural protein. For example : tubulin. 

RECEPTOR REGULATION

     •Down Regulation : when receptors become desensitized or decrease in number when exposed to agonist repeatedly. 
     •UP Regulation : when receptors supersensitive to agonist via synthesis of additional receptors on chronic administration of antagonist. 

SPARE RECEPTORS
     • When maximal response can be elicited by an agonist at the concentration that does not result in occupancy of all available receptors, the receptors that are not occupied are called spare receptors. 
                                       OR
We can simply define it as more(extra) receptor available than needed to elicit the maximum response. 


=>When drug binds with receptor, it form drug receptor complex, Which initiated alterations in biochemical or mollecular activity of a cell by process called Signal transduction. 


SIGNAL TRANSDUCTION

Drug act as signals, and receptors act as signal detectors. A drug is termed as “agonist” if its binds to a site on receptor protein and activated it to initiates a series of reactions that ultimately result in specific intracellular response. 
  • “2nd messenger” or effector mollecules are part of cascade of events that translate agonist binding in to cellular response. 

1. The Drug Receptor complex

  
      • Cells have many different types of receptors each of which is specific for a particular agonist and produce a unique response. For example : cardiac cell membranes contain ‘B-adrenergic receptors that binds and response to epinephrine or norepinephrine. Cardiac cells also contain muscarinic receptors that binds and response to acetylcholine. 
These 2 receptors population control heart vital functions. 


=>The magnitude of the cellular response is proportional to the number of drug-receptor complexes. More the D-R complex more will be response.
When drug binds with recptors, it produce a measurable response via :

2. Major receptor families

 
      • A receptor is defined as any biological mollecule to which drug binds and produce response. Ghus enzymes, nucleic acids & structural proteins can act as receptors for drug or endogenous agonists. How ever richest source of receptors are membrane bound proteins. There are following types of receptors : 

   (i) Cell membrane receptors coupled to ion/ligand gated channels


         • The extracellular portion of ligand gated ion channels contains drug-binding site. The site regulated the opening of pore through which ions can flow across cell membranes. The channel us usually closed untill the receptor is activated by an agonist, which open the channel for few milli seconds.

For Example : acetylcholine stimulated the nicotinic receptors that cause the channels to open, that allows Na influx and K outflux across the C.M(cell membrane) of nuerons or muscle cells. The change in ionic concentration across C.M generated an action potential in neuron and contraction in skeletal and cardiac muscles. 
On the other hand GABA receptor increase the Chlorine influx, resulting in hyperpolarization of neurons and less chance of generating action potential. 
Another example is Local anesthetics : these will bind with voltage gated Na channels, inhibiting the Na influx and decreasing the neuronal conduction. 



   (ii) Transmembrane G- protein-coupled receptors: 


              • The extracellular portion of this receptor contains the ligand-binding site and the intracellulular portion interacts(when activated) wit G protein. 
G proteins are of many kinds ( Gs, Gi, Gq) but all these types are composed of 3 protein subunits. The alpha subunit binds with GTP and Beta & gamma subunits binds anchor the G protein in the cell membrane. 
   — Gs => stimulates the adenyl cyclase that cause the conversion of ATP to cAMP then cAMP activates protein kinase A which on further promotes phosphorylation of protein (tissue specific enzyme) activation. 
Example : Histamine(H2) and serotonin(5HT) receptors. 

   —Gi => It inhibits the adenyl cyclase that will cause inhibition of cAMP production. 
Example : sympthatic(alpha 2) and muscarinic(M2) receptors. 

    —Gq => It activates phospholipase C which increase the IP3 production that cause Calcium release from sarcoplasmic reticulum. Ca++ activates the protein kinase C that cause the phosphorylation of proteins.
Example : aplha1, M1, M3, angiontensin (AG11) , & opiod receptors. 


     (iii)  Intracellular receptors : 


                • This family of receptors differs comsiderably from others in that the receptor is entirely intracellular. Therefore ligand must have lipid solubility to diffuse in to cell to interact with receptors. 
  —- when lipid soluble ligand enter in Cell it form harmone-receptor complex, which will cause stimulation of response elements on DNA that modifies gene expression( formation of mRNA from DNA and translate information of mRNA to make proteins)


Othe targets of intracellular ligands are structural proteins, enzymes, RNA, ribosomes. 
  • They have slow onset but long duration of action. 

Comments

Popular posts from this blog

Autonomic Nervous System Anatomy and Physiology

           The Autonomic       Nervous System   • The Autonomic Nervous System(ANS) along with endocrine system coordinates  the regulation amd integeration of body functions.    •The ANS largerly independent (autonomous) in that its activities are not under direct conscious control. It is concenred primarily with visceral functions such as cardiac output, blood flow to various organs and digestions, which is necessary for life.    • Drugs that produce their primary therpeutic effect by mimicking or altering the functions of ANS are called autonomic drugs.    - The autonomic agents act either by stimulating portion of ANS or by blocking the action of autonomic nerves .    Nervous System overview :    • The N.S is divided into 2 anatomical divisions : The Central Nervous System which is composed of brain & spinal cord and the Peripheral Nervous System .    • Peripheral nervous system includes neurons which located outside the brain and spinal cord.    • The peripheral nervous syste

AGONIST & ANTAGONIST with types

AGONIST       • Agonist is a chemical(drug) that binds to the receptor and activates the receptor to produce biological response.                                             OR       • Agonist is a drug that produce effects on endogenous compounds, when it interacts with it’s receptor.     => Agonists are of following types:      (1) Full agonists     (2) Partial agonists     (3) Inverse agonists (1) Full Agonists       • If a drug binds to a receptor and produce maximal biological response that mimics the response to endogenous ligand is called full agonist.   - All full agonists for a receptor population should produce the same E max. For Example : phenylephrine is a full agonist at alpha1-adrenoceptors, because it produce the same E max as the endogenous ligand, norepinephrine. Upon binding with aplha1-adrenoceptors on vascular smooth muscle, both phenylephrine and norepinephrine stablize the receptor in its active state, thereby increasing the Gq activation. Activation of Gq i

Mechanism of absorption of Drugs

    Absorption of Drugs • Absorption concerns the process of entry of drug in to systemic circulation from site of administration.  •The rate and extent of absorption depend on:   -the environment where the drug is absorbed   -chemical characteristics of drug   -route of administration (which influence bioavailability) • The route of administration other than intravenous may result in partial absorption and lower bioavailability.  (A) Mechanism of absorption of drug from GIT • Depending upon their chemical properties , drugs may be absorbed from GI tract by passive diffusion, facilitated diffusion, active transport or endocytosis.    (1) Passive diffusion :       • In this drug move from area of high concentration to area of lower concentration.                  - also known as non-ionic diffusion    - The driving force for this process is concentration or       electrochemical gradient.     - P.D does not require carrier, is not saturable, and shows low structural specifity.     - The

Elimination of the Drug

          Drug Elimination   • Drugs must be sufficiently polar to be eliminated from the body.  • Removal of drugs from body occur via number of routes; the most important is elimination through kidney in to urine.  Renal Elimination of Drug • A drug passes through several process in the kidney before elimination, Glomerular filtration, tubular seceration , and passive tubular reabsorption.     (1) Glomerular filteration :   • Drugs enter the kidney through renal artries, which divide to form a glomerular capillary plexus. Free drug (not bound to albumin) flows through the capillary bed into bowman’s space as a part of glomerular filterate.    > Glomerular filteration rate is normally about 120mL/min. But may decrease sugnificantly in renal disease.       > pH and lipid solubility do not influence the passage of drugs into glomerular filterate.      > Variation in GFR and protein binding to drugs donot affect this process.    > water and polar compounds easily enter in gl

Cholinergic neuron & Cholinergic Receptors

 •Drugs affecting the autonomic nervous system(ANS) are divided into two groups according to the type of neuron involved in mechanism of action.    •The cholinergic drugs, which act on receptors activated by acetylcholine(Ach), Where as adrenergic drugs act on receptors stimulated by epinephrine or norepinephrine.    •The cholinergic drugs act by either stimulating or blocking the receptors of the ANS.  The cholinergic neuron   • The preganglionic fibres terminating in adrenal medulla.    • The postganglionic fibres of parasympathetic division use ACh as a neurotransmitter.  The postganglionic sumpayhetic division of sweat glands also uses ACh.    • Ina ddition, cholinergicneurons innervate the muscles of somatic system and play an important role in CNS.  NEUROTRANSMISSION @ CHOLINERGIC NEURON :   • Neurotransmission at cholinergic neurons involves 6 sequential steps :   (1) Synthesis of ACh   (2) Storage of ACh    (3) Release of ACh   (4) Binding of ACh to the receptor   (5) Degradati

Cholinergic Drugs (direct acting) Part-2

  (3) CARBACHOL (Carbamylcholine )   • Carbachol is is an ester of carbamic acid and poor substrate for AChEsterase. It is biotransformed by other esters at very slow rate.    • Carbachol has both Muscarinic and Nicotinic actions. Functions   (i) Actions :    • Carbachol has profound effects on both Cardiovascular system and GI system.    • It has ganglion stimulating activity and it may first stimulate and then depress these systems.    • It can cause release of epinephrine from adrenal medulla by its nicotinic functions.   On Eye :     • It cause miosis    • It cause spasm of accomodatiom in which the ciliary muscle of the eye remains in a constant state of contraction.    • Carbachol is also used to stimulate micturation by contraction of detrusor muscle. (ii) Therapeutic uses :     • Carbachol has high potency, receptor non-selectivity and relatively long duration of action.     • Carbachol is rarely used.     • Carbachol administered ocularly to induce miosis to reduce the intr

Cholinergic Drugs (Direct acting) Part-1

Cholinergic Agonists (direct acting)  • Cholinergic agonists mimic the effect of acetylcholine by binding directly to cholinoceptors (muscarinic & nicotinic).   • These agents are classified into 2 groups;     (1) Choline esters : it includes endogenous ACh and synthetic esters of choline. Such as Carbachol & Bethanechol .     (2) Naturally occuring Alkaloids : Nicotine & Pilocarpine .    • All direct-actings Cholinergic drugs have longer duration of action than Acetylcholine.    (1) ACETYLCHOLINE   • ACh is the quaternary ammonium compound that cannot penetrates membranes.    • It is nuerotransmitter of parasympathetic, somatic nerves & autonomic ganglia.    • It lacks the therapeutics importance b/c of multiple actions and its rapid inactivation by the cholinesterases.    • ACh has both muscarinic and nicotinic activity.    Functions :     (a) Decrease in heart rate and cardiac output :      • ACh mimics the effects of vagal stimulation on the heart.      • If in

Drug clearance & Half Life & Dose

Drug Clearance It refers to the ratio of rate of drug elimination to the concentration of drug in biological fluid(C).                       CL = rate of elimination / C Rate of elimination   • For most of the drugs, elimination is not saturable & rate of drug elimination is directly proportional to concentration.                     Rate of elimination = CL x C ==> The difference between drug clearance and drug elimination is that :     • Clearance is Volume of blood cleared of drug per unit time and Elimination is amount of drug cleared from blood per unit time.  Total Body Clearance   • The total body systemic clearance , CLtotal is the sum of all clearances from drug metabolising and drug eliminating organs.                                         OR   • Dividing the rate of elimination at each organ by concentration of drug presented to it yeilds respective clearance at that organ and sum of these is total body clearance.                CLx = rate of elimination x / C      

Drug Clearance by Biotranformation

Drug clearance : Once a drug enters into the body, the process of elimination begins. The three major routes of eliminations are: (i) Hepatic metabolism (ii) Biliary elimination (iii) Urinary excreation Excreation is irreversible removal of the drug from the body. It involves BIOTRANSFORMATION & EXCREATION.   •> Metabolism results in products with increase polarity, which allows the drug to be eliminated.  •> Clearance(CL) estimates the vomume of blood from which  the drug is cleared per unit of time.                            CL = 0.693 x V d / t  1/2    - W here T 1/2 is the elimination half life, Vd is apparent volume of distribution and 0.693 is natural log. BIOTRANSFORMATION               • The general principle of biotransformation is the metabolic conversion of drug mollecule to more water soluble metabolites that are more readily excreated.   - In many cases, metabolism of drug results in its conversion to compounds that have little or no pharmacological activity